Group Members

 

Dr Louis Allott (Group Leader)
Lecturer in Translational Radiopharmaceutics - University of Hull
Head of Radiochemistry Innovation - Molecular Imaging Research Centre (MIRC), Castle Hill Hospital

 

 

Louis completed his master’s degree in chemistry (MChem) at the University of Hull in 2011 and continued studying for a PhD in PET Radiochemistry (2011 – 2014). He started post-doctoral research in the Division of Radiotherapy and Imaging, Institute of Cancer Research (2014 – 2017) under the supervision of Dr Graham Smith; followed by a position with Prof Eric Aboagye in the Faculty of Medicine, Imperial College London as a Post-doctoral Research Associate and Chemistry Team Leader (2017 – 2020). In January 2021, Louis returned to the University of Hull as Lecturer in Translational Radiopharmaceutics where he joined the team to set up the new Molecular Imaging Research Centre and establish  a new research group. His group develops small-molecule and biomolecule PET radiochemistry, advanced automated radiosynthesis protocols and novel radiopharmaceuticals for clinical translation

Curriculum Vitae | Publications | University Profile

PhD Students

To Be Announced

A new PhD student will be starting in the group this September 2022. 

Zixuan Yang 

Zixuan (Noble) is working on a collaborative project between the Allott and Aboagye group where she develops new targeted therapeutics for cancer. She is based at Imperial College London.

(Co-supervision with Prof Eric Aboagye, Imperial College London)

Visiting Researchers

Yiru Hou

Summer 2022

Xiaoyan Yang

Summer 2022

Yiru and Xiaoyan are visiting research scientists from École nationale supérieure de chimie de Lille, University in Villeneuve-d'Ascq, France. They are working on developing radiochemistry precursors, as well as new fluorine-18 prosthetic group strategies for labelling peptides.